Charlotte Warren-Gash

Charlotte Warren-Gash

Auto-generated profile, based on publicly available information

Charlotte Warren-Gash

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2018 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
LLLiang-Yu Lin
Liang-Yu Lin
CWCharlotte Warren-Gash
Charlotte Warren-Gash
LSLiam Smeeth
Liam Smeeth
PCPau-Chung Chen
Pau-Chung Chen
Electronic health records (EHRs) can provide researchers with extraordinary opportunities for population-based research. The National Health Insurance system of Taiwan was established in 1995 and covers more than 99.6% of the Taiwanese population; this system's claims data are released as the National Health Insurance Research Database (NHIRD). All data from primary outpatient departments and inpatient hospital care settings after 2000 are included in this database. After a change and update in 2016, the NHIRD is maintained and regulated by the Data Science Centre of the Ministry of Health and Welfare of Taiwan. Datasets for approved research are released in three forms: sampling datasets comprising 2 million subjects, disease-specific databases, and full population datasets. These datasets are de-identified and contain basic demographic information, disease diagnoses, prescriptions, operations, and investigations. Data can be linked to government surveys or other research datasets. While only a small number of validation studies with small sample sizes have been undertaken, they have generally reported positive predictive values of over 70% for various diagnoses. Currently, patients cannot opt out of inclusion in the database, although this requirement is under review. In conclusion, the NHIRD is a large, powerful data source for biomedical research.

1 October 2009 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
CWCharlotte Warren-Gash
Charlotte Warren-Gash
LSLiam Smeeth
Liam Smeeth
AHAndrew C Hayward
Andrew C Hayward

21 March 2018 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
CWCharlotte Warren-Gash
Charlotte Warren-Gash
RBRuth Blackburn
Ruth Blackburn
HWHeather Whitaker
Heather Whitaker
JMJim McMenamin
Jim McMenamin
AHAndrew C. Hayward
Andrew C. Hayward
While acute respiratory tract infections can trigger cardiovascular events, the differential effect of specific organisms is unknown. This is important to guide vaccine policy.Using national infection surveillance data linked to the Scottish Morbidity Record, we identified adults with a first myocardial infarction or stroke from January 1, 2004 to December 31, 2014 and a record of laboratory-confirmed respiratory infection during this period. Using self-controlled case series analysis, we generated age- and season-adjusted incidence ratios (IRs) for myocardial infarction (n=1227) or stroke (n=762) after infections compared with baseline time.We found substantially increased myocardial infarction rates in the week afterStreptococcus pneumoniaeand influenza virus infection: adjusted IRs for days 1–3 were 5.98 (95% CI 2.47–14.4) and 9.80 (95% CI 2.37–40.5), respectively. Rates of stroke after infection were similarly high and remained elevated to 28 days: day 1–3 adjusted IRs 12.3 (95% CI 5.48–27.7) and 7.82 (95% CI 1.07–56.9) forS. pneumoniaeand influenza virus, respectively. Although other respiratory viruses were associated with raised point estimates for both outcomes, only the day 4–7 estimate for stroke reached statistical significance.We showed a marked cardiovascular triggering effect ofS. pneumoniaeand influenza virus, which highlights the need for adequate pneumococcal and influenza vaccine uptake. Further research is needed into vascular effects of noninfluenza respiratory viruses.

9 October 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
CWCharlotte Warren-Gash
Charlotte Warren-Gash
AHAndrew C. Hayward
Andrew C. Hayward
HHHarry Hemingway
Harry Hemingway
SDSpiros Denaxas
Spiros Denaxas
STSara L. Thomas
Sara L. Thomas
LSLiam Smeeth
Liam Smeeth
Background. An association between infections and vascular events has been observed, but the specific effect of influenza and influenza-like illnesses on triggering acute myocardial infarction (AMI) is unclear. Methods. Episodes of first AMI from 1 January 2003 through 31 July 2009 were identified using linked anonymized electronic medical records from the Myocardial Ischaemia National Audit Project and the General Practice Research Database. Self-controlled case series analysis was used to investigate AMI risks after consultation for acute respiratory infection. Infections were stratified by influenza virus circulation, diagnostic code, and vaccination status to assess whether influenza was more likely than other infections to trigger AMI. Results. Of 22 024 patients with acute coronary syndrome, 11 208 met the criterion of having had their first AMI at the age of ≥40 years, and 3927 had also consulted for acute respiratory infection. AMI risks were significantly raised during days 1–3 after acute respiratory infection (incidence ratio, 4.19 [95% confidence interval, 3.18–5.53], with the effect tapering over time. The effect was greatest in those aged ≥80 years (P = .023). Infections occurring when influenza was circulating and those coded as influenza-like illness were associated with consistently higher incidence ratios for AMI (P = .012). Conclusions. Influenza and other acute respiratory infections can act as a trigger for AMI. This effect may be stronger for influenza than for other infections. Clinical trials registration. NCT01106196.

18 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CWCharlotte Warren-Gash
Charlotte Warren-Gash
HFHarriet J. Forbes
Harriet J. Forbes
EWElizabeth Williamson
Elizabeth Williamson
JBJudith Breuer
Judith Breuer
AHAndrew C. Hayward
Andrew C. Hayward
LSLiam Smeeth
Liam Smeeth
Interest is growing in the role of infectious agents in the pathogenesis of dementia, but current evidence is limited. We conducted a systematic review and meta-analysis to investigate the effect of any of eight human herpesviruses on development of dementia or mild cognitive impairment (MCI). We searched the Cochrane Library, Embase, Global Health, Medline, PsycINFO, Scopus, Web of Science, clinical trials registers and grey literature sources from inception to December 2017 for observational studies with cohort, case control or self-controlled designs, or randomised controlled trials of interventions against herpesviruses. Pooled effect estimates and 95% confidence intervals (CIs) were generated through random effects meta-analyses across studies with the same design, outcome, and virus type, method and site of measurement. We included 57 studies across various geographic settings. Past infection with herpesviruses, measured by IgG seropositivity, was generally not associated with dementia risk. A single cohort study rated moderate quality showed an association between varicella zoster virus reactivation (ophthalmic zoster) and incident dementia (HR 2.97; 95%CI, 1.89 to 4.66). Recent infection with, or reactivation of, herpes simplex virus type 1 or type 1/2 unspecified, cytomegalovirus and human herpes virus-6 measured by serum IgM, high titre IgG or clinical disease may be associated with dementia or MCI, though results were inconsistent across studies and overall evidence rated very low quality. Longitudinal population studies with robust repeated virus measurements taken sufficiently proximal to dementia onset are needed to establish whether, when and among whom herpesviruses affect dementia risk.

6 January 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
RBRuth Blackburn
Ruth Blackburn
HZHonxin Zhao
Honxin Zhao
RPRichard Pebody
Richard Pebody
AHAndrew Hayward
Andrew Hayward
CWCharlotte Warren-Gash
Charlotte Warren-Gash
Acute respiratory infections are associated with increased risk of myocardial infarction (MI) and stroke; however, the role of different organisms is poorly characterized. Time-series analysis of English hospital admissions for MI and stroke (age-stratified: 45–64, 65–74, ≥75 years), laboratory-confirmed viral respiratory infections, and environmental data for 2004–2015. Weekly counts of admissions were modeled using multivariable Poisson regression with weekly counts of respiratory viruses (influenza, parainfluenza, rhinovirus, respiratory syncytial virus [RSV], adenovirus, or human metapneumovirus [HMPV]) investigated as predictors. We controlled for seasonality, long-term trends, and environmental factors. Weekly hospital admissions in adults aged ≥45 years averaged 1347 (interquartile range [IQR], 1217–1541) for MI and 1175 (IQR, 1023–1395) for stroke. Respiratory infections ranged from 11 cases per week (IQR, 5–53) for influenza to 55 (IQR, 7–127) for rhinovirus. In the adjusted models, all viruses except parainfluenza were significantly associated with MI and ischemic stroke admissions in those aged ≥75. Among 65- to 74-year-olds, adenovirus, rhinovirus, and RSV were associated with MI but not ischemic stroke admissions. Respiratory infections were not associated with MI or ischemic stroke in people aged 45–64 years, nor with hemorrhagic stroke in any age group. An estimated 0.4%–5.7% of MI and ischemic stroke admissions may be attributable to respiratory infection. We identified small but strongly significant associations in the timing of respiratory infection (with HMPV, RSV, influenza, rhinovirus, and adenovirus) and MI or ischemic stroke hospitalizations in the elderly. NCT02984280.